NIAID Concerned AstraZeneca May Have Given Outdated Info From COVID-19 Vaccine US Trial
AstraZeneca Plc (LON: AZN) may have included outdated data related to the U.S. trials of its COVID-19 vaccine that resulted in an incomplete view of the efficacy data, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Monday.
